Skip to main content
. 2024 Jan 4;10(1):e729. doi: 10.1002/osp4.729

TABLE 4.

Circulating insulin levels before and after sleeve gastrectomy.

Non‐diabetes n = 8 Within group effect of time Diabetes n = 8 Within group effect of time
Baseline 6W 6M Baseline 6W 6M
Fasting insulin (μU/mL) 10.7 ± 5.3 6.2 ± 4* 5.0 ± 2.5* F = 7.5, p = 0.01 17.4 ± 11.2 9.2 ± 5.1 6.7 ± 3.8* F = 5.7, p = 0.02
30‐min insulin (μU/mL) 105.3 ± 95 109.1 ± 149 122.2 ± 92.8 NS 34.1 ± 20 64.5 ± 42.0* 79.8 ± 44.2* F = 5.8, p = 0.01
1‐h insulin (μU/mL) 82.3 ± 35.1 115.2 ± 166.8 96.4 ± 107 NS 38.7 ± 27.2 83.5 ± 65.8 80.3 ± 29.3 NS
2‐h insulin (μU/mL) 80.03 ± 53.4 90.7 ± 208 12 ± 7.4 NS 36.6 ± 33.1 44.1 ± 33.7 18.9 ± 14.2 NS
Insulin AUC (uU h/mL) 161 ± 71.4 133 ± 123 140 ± 95 NS 74 ± 37.7 129 ± 82.0 112 ± 39.0 NS
Matsuda index 3.8 ± 1.8 6.1 ± 3.0 6.4 ± 2.0 NS 2.7 ± 2.0 3.7 ± 2.2 4.6 ± 2.1** F = 3.9, p = 0.046
HOMA‐IR 2.5 ± 1.4 1.4 ± 0.8* 1.0 ± 0.5* F = 7.5, p = 0.01 8.4 ± 6.5†† 2.8 ± 2.0*,† 1.7 ± 1.0* F = 10.2, p = 0.01
Disposition index 4.4 ± 3.6 8.3 ± 4.7 11.7 ± 10.3* F = 5.2, p = 0.05 0.9 ± 1.5 1.7 ± 2.2††† 3.5 ± 2.3*,† F = 5.2, p = 0.02

Abbreviation: NS, not significant.

Post‐hoc Bonferroni comparisons: *p < 0.05, compared to baseline data, within group comparison. **p < 0.01, compared to baseline, within group comparison. ***p < 0.001, compared to baseline, within group comparison.

Group Comparisons: p < 0.05, group comparison at the same time point. †† p < 0.01, group comparison at the same time point. ††† p < 0.001, group comparison at the same time point.